In clinical cases of ischemic stroke, elevated levels of substance P (SP) have been documented in the serum of human patients with complete stroke, transient ischemic attack (TIA), as well as in studies involving animal stroke models [156, 157]. This evidence concerns the gene TAC1 and transient ischemic attack.